Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
FBXW2 inhibits prostate cancer proliferation and metastasis via promoting EGFR ubiquitylation and degradation.
Cell Mol Life Sci. 2022 May 2;79(5):268. doi: 10.1007/s00018-022-04320-3.
Cell Mol Life Sci. 2022.
PMID: 35499593
Free PMC article.
RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy.
Yang Z, Fu B, Zhou L, Xu J, Hao P, Fang Z.
Yang Z, et al.
BMC Urol. 2019 Jul 24;19(1):69. doi: 10.1186/s12894-019-0497-x.
BMC Urol. 2019.
PMID: 31340801
Free PMC article.
Item in Clipboard
Cite
Cite